Drug Profile
CDRI 82437
Alternative Names: Compound 82437Latest Information Update: 15 Aug 2007
Price :
$50
*
At a glance
- Originator Central Drug Research Institute
- Class Anthelmintics; Benzimidazoles; Small molecules
- Mechanism of Action Catalase inhibitors; Glutathione peroxidase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Helminthiasis
Most Recent Events
- 11 Sep 1995 No-Development-Reported for Helminthiasis in India (unspecified route)
- 09 Dec 1994 Preclinical development for Helminthiasis in India (unspecified route)